C17orf50
geneOn this page
Summary
C17orf50 (chromosome 17 open reading frame 50, HGNC:29581) is a protein-coding gene on chromosome 17q12, encoding Uncharacterized protein C17orf50 (Q8WW18).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 13 total — 1 pathogenic
- MANE Select transcript:
NM_145272
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29581 |
| Approved symbol | C17orf50 |
| Name | chromosome 17 open reading frame 50 |
| Location | 17q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000270806 |
| Ensembl biotype | protein_coding |
| Entrez | 146853 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000603305, ENST00000604830, ENST00000605587
RefSeq mRNA: 1 — MANE Select: NM_145272
NM_145272
CCDS: CCDS42298
Canonical transcript exons
ENST00000605587 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003462919 | 35760887 | 35760954 |
| ENSE00003525875 | 35764426 | 35765079 |
| ENSE00003602126 | 35764007 | 35764325 |
Expression profiles
Bgee: expression breadth ubiquitous, 118 present calls, max score 95.14.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1705 / max 174.5699, expressed in 4 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 160378 | 0.1520 | 4 |
| 160377 | 0.0106 | 3 |
| 160376 | 0.0042 | 2 |
| 160379 | 0.0036 | 3 |
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 95.14 | gold quality |
| right testis | UBERON:0004534 | 94.96 | gold quality |
| sperm | CL:0000019 | 92.80 | gold quality |
| testis | UBERON:0000473 | 91.61 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.54 | silver quality |
| adult organism | UBERON:0007023 | 80.89 | gold quality |
| kidney epithelium | UBERON:0004819 | 63.63 | gold quality |
| sural nerve | UBERON:0015488 | 62.03 | gold quality |
| biceps brachii | UBERON:0001507 | 61.03 | gold quality |
| deltoid | UBERON:0001476 | 60.32 | gold quality |
| right uterine tube | UBERON:0001302 | 60.27 | gold quality |
| tibialis anterior | UBERON:0001385 | 60.13 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 59.07 | gold quality |
| corpus epididymis | UBERON:0004359 | 58.84 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 58.65 | gold quality |
| cauda epididymis | UBERON:0004360 | 58.46 | gold quality |
| bronchial epithelial cell | CL:0002328 | 56.69 | gold quality |
| myocardium | UBERON:0002349 | 56.60 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 56.50 | gold quality |
| nucleus accumbens | UBERON:0001882 | 56.06 | gold quality |
| bronchus | UBERON:0002185 | 55.94 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 55.51 | gold quality |
| gingival epithelium | UBERON:0001949 | 55.38 | gold quality |
| caput epididymis | UBERON:0004358 | 55.20 | gold quality |
| cartilage tissue | UBERON:0002418 | 55.09 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.98 | gold quality |
| gingiva | UBERON:0001828 | 54.38 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| jejunal mucosa | UBERON:0000399 | 54.20 | gold quality |
| ileal mucosa | UBERON:0000331 | 54.15 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
19 targeting C17orf50, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-5695 | 99.41 | 67.48 | 1047 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-6848-5P | 98.81 | 65.49 | 1126 |
| HSA-MIR-6846-5P | 98.81 | 65.86 | 1121 |
| HSA-MIR-4710 | 98.61 | 65.96 | 1048 |
| HSA-MIR-4257 | 97.86 | 68.05 | 1190 |
| HSA-MIR-4640-5P | 97.42 | 66.33 | 1543 |
| HSA-MIR-4726-5P | 97.24 | 65.67 | 1299 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-4790-3P | 96.63 | 67.08 | 806 |
| HSA-MIR-1237-5P | 95.38 | 62.21 | 451 |
| HSA-MIR-4488 | 95.38 | 62.00 | 443 |
| HSA-MIR-4697-5P | 95.38 | 61.72 | 457 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 1700020L24Rik | ENSMUSG00000035085 |
| rattus_norvegicus | C10h17orf50 | ENSRNOG00000049757 |
Protein
Protein identifiers
Uncharacterized protein C17orf50 — Q8WW18 (reviewed: Q8WW18)
All UniProt accessions (3): Q8WW18, A0A075B7C2, A0A075B7E2
RefSeq proteins (1): NP_660315* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029174 | DUF4637 | Domain |
Pfam: PF15470
UniProt features (5 total): compositionally biased region 2, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WW18-F1 | 58.44 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
HP1SITEFACTOR_Q6, TGGAAA_NFAT_Q4_01, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, CHYLA_CBFA2T3_TARGETS_UP, PEDRIOLI_MIR31_TARGETS_UP, MIR12128, MIR329_5P, MIR4257, chr17q12, GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN, WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME, GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN, GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP, GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN, GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
132 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C17orf50 | SPMAP1 | A8MV24 | 693 |
| C17orf50 | CFAP97D1 | B2RV13 | 691 |
| C17orf50 | SPEM2 | Q0P670 | 668 |
| C17orf50 | TBC1D3K | A0A087X1G2 | 570 |
| C17orf50 | KRTAP9-7 | A8MTY7 | 545 |
| C17orf50 | CDRT15L2 | A8MXV6 | 507 |
| C17orf50 | TBC1D3H | P0C7X1 | 475 |
| C17orf50 | KRTAP9-8 | Q9BYQ0 | 447 |
| C17orf50 | TBC1D28 | Q2M2D7 | 445 |
| C17orf50 | OR1E2 | P47887 | 433 |
| C17orf50 | TBC1D3D | A0A087WVF3 | 432 |
| C17orf50 | SLC35G3 | Q8N808 | 418 |
| C17orf50 | SLC35G6 | P0C7Q6 | 418 |
| C17orf50 | OR1D5 | P58170 | 417 |
| C17orf50 | CCDC144A | A2RUR9 | 415 |
IntAct
34 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C17orf50 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| C17orf50 | CIB3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT34 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C17orf50 | CTNNA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C17orf50 | ZNF587 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C17orf50 | PCSK5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VWC2L | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-5 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ANKS1A | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| KRTAP10-8 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
| VWC2L | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRTAP10-5 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ANKS1A | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CIB3 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KRT34 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF587 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PCSK5 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CTNNA3 | C17orf50 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (12): C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GTK4, A0A1B0GTK5, A0JNL8, A2RUT3, A4D250, B2KGE5, F1MQW7, F2Z3F1, F5HHT4, O93195, O95411, P04610, P05905, P0C733, P0C7M3, P0DP71, P16722, P17758, P47939, P47940, P57738, Q0VD86, Q1HVB5, Q1RN00, Q1X6Y7, Q1X6Z1, Q1X6Z2, Q3ZN08, Q5PR19, Q5PXH1, Q5TC04, Q5TEZ4, Q64902, Q66669, Q66HF0, Q67863, Q6DGF6, Q6UYE1, Q7L4S7, Q8AZJ3
Diamond homologs: Q8C1R3, Q8WW18
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2574697 | GRCh37/hg19 17q11.2-12(chr17:30572862-35843988) | Pathogenic |
SpliceAI
462 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:35764004:CA:C | acceptor_loss | 0.9900 |
| 17:35764005:A:AG | acceptor_gain | 0.9900 |
| 17:35764006:G:GG | acceptor_gain | 0.9900 |
| 17:35764006:GGT:G | acceptor_gain | 0.9900 |
| 17:35764006:GGTGT:G | acceptor_gain | 0.9900 |
| 17:35764005:AG:A | acceptor_gain | 0.9800 |
| 17:35764006:GG:G | acceptor_gain | 0.9800 |
| 17:35760950:GCATG:G | donor_gain | 0.9700 |
| 17:35760951:CATGG:C | donor_loss | 0.9700 |
| 17:35760955:G:GC | donor_loss | 0.9700 |
| 17:35760956:T:A | donor_loss | 0.9700 |
| 17:35760955:G:GG | donor_gain | 0.9500 |
| 17:35763998:G:A | acceptor_gain | 0.9500 |
| 17:35760953:TG:T | donor_gain | 0.9400 |
| 17:35760954:GG:G | donor_gain | 0.9400 |
| 17:35760957:GA:G | donor_loss | 0.9400 |
| 17:35762764:C:T | donor_gain | 0.9300 |
| 17:35764005:AGGT:A | acceptor_gain | 0.9300 |
| 17:35764006:GGTG:G | acceptor_gain | 0.9300 |
| 17:35764689:T:TA | acceptor_gain | 0.9200 |
| 17:35764691:G:C | acceptor_gain | 0.9200 |
| 17:35760946:A:G | donor_gain | 0.9100 |
| 17:35760951:CATG:C | donor_gain | 0.9100 |
| 17:35764161:AGCGG:A | donor_gain | 0.9100 |
| 17:35760945:GA:G | donor_gain | 0.9000 |
| 17:35764238:T:TA | donor_gain | 0.8800 |
| 17:35764239:G:GA | donor_gain | 0.8800 |
| 17:35760952:ATG:A | donor_gain | 0.8700 |
| 17:35764160:T:TA | donor_gain | 0.8700 |
| 17:35764240:GCGCT:G | donor_gain | 0.8700 |
AlphaMissense
1116 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:35764514:T:C | F141L | 0.978 |
| 17:35764516:C:A | F141L | 0.978 |
| 17:35764516:C:G | F141L | 0.978 |
| 17:35764518:G:A | C142Y | 0.975 |
| 17:35764540:C:A | H149Q | 0.971 |
| 17:35764540:C:G | H149Q | 0.971 |
| 17:35764026:G:C | W11C | 0.969 |
| 17:35764026:G:T | W11C | 0.969 |
| 17:35764517:T:A | C142S | 0.968 |
| 17:35764518:G:C | C142S | 0.968 |
| 17:35764579:C:A | H162Q | 0.966 |
| 17:35764579:C:G | H162Q | 0.966 |
| 17:35764517:T:C | C142R | 0.965 |
| 17:35764526:T:A | C145S | 0.965 |
| 17:35764527:G:C | C145S | 0.965 |
| 17:35764538:C:G | H149D | 0.964 |
| 17:35764503:G:A | C137Y | 0.961 |
| 17:35764519:C:G | C142W | 0.958 |
| 17:35764564:C:A | H157Q | 0.955 |
| 17:35764564:C:G | H157Q | 0.955 |
| 17:35764526:T:C | C145R | 0.954 |
| 17:35764502:T:A | C137S | 0.947 |
| 17:35764503:G:C | C137S | 0.947 |
| 17:35764569:T:A | V159D | 0.947 |
| 17:35764452:G:A | C120Y | 0.944 |
| 17:35764518:G:T | C142F | 0.943 |
| 17:35764451:T:A | C120S | 0.942 |
| 17:35764452:G:C | C120S | 0.942 |
| 17:35764515:T:C | F141S | 0.941 |
| 17:35764024:T:A | W11R | 0.938 |
dbSNP variants (sampled 300 via entrez): RS1002296935 (17:35759657 C>T), RS1002347829 (17:35759820 C>T), RS1002981605 (17:35764357 G>A), RS1004296619 (17:35759886 T>A), RS1004753345 (17:35760144 T>A,C), RS1005463380 (17:35763272 A>C), RS1007148891 (17:35761852 C>T), RS1007481056 (17:35760263 C>T), RS1008534228 (17:35759382 G>A), RS1009453032 (17:35765030 C>A), RS1010891691 (17:35765162 C>A,T), RS1011228620 (17:35764017 C>G,T), RS1011504374 (17:35759441 C>A), RS1013386313 (17:35761770 C>A,G), RS1013468710 (17:35763162 G>A)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:614527
GenCC curated gene-disease
Mondo (1): chromosome 17q12 deletion syndrome (MONDO:0013797)
Orphanet (1): 17q12 microdeletion syndrome (Orphanet:261265)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007001_12 | Cerebrospinal AB1-42 levels in normal cognition | 4.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004670 | beta-amyloid 1-42 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT01238250 | Not specified | RECRUITING | Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): chromosome 17q12 deletion syndrome